Hepatitis Monthly

Published by: Kowsar

Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz

Malgorzata Tyczyno 1 , * , Waldemar Halota 1 , Wojciech Nowak 1 and Małgorzata Pawlowska 1
Authors Information
1 Department of Infectious Diseases and Hepatology, Nicolaus Copernicus University, Bydgoszcz, Poland
Article information
  • Hepatitis Monthly: May 01, 2014, 14 (5); e14559
  • Published Online: May 3, 2014
  • Article Type: Brief Report
  • Received: September 16, 2013
  • Revised: December 12, 2013
  • Accepted: December 25, 2013
  • DOI: 10.5812/hepatmon.14559

To Cite: Tyczyno M, Halota W, Nowak W, Pawlowska M. Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz, Hepat Mon. 2014 ; 14(5):e14559. doi: 10.5812/hepatmon.14559.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2): 41-6[PubMed]
  • 2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases. 2005; 5(9): 558-67
  • 3. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000; 13(2): 223-35[PubMed]
  • 4. Fattovich G, Ribero ML, Pantalena M, Diodati G, Almasio P, Nevens F, et al. Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J Viral Hepat. 2001; 8(3): 206-16[PubMed]
  • 5. Singh B, Verma M, Verma K. Markers for transfussion-associaced hepatitis in north Indian blood donors: prevalence and trends. Jpn I Infect Dis. 2004; 57(2): 49-51
  • 6. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 2008; 8: 69[DOI][PubMed]
  • 7. Nguyen MH, Keeffe EB. Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2005; 3
  • 8. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis. 2006; 10(4): 272-7[DOI][PubMed]
  • 9. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001; 345(1): 41-52[DOI][PubMed]
  • 10. Meyer MF, Wedemeyer H, Monazahian M, Dreesman J, Manns MP, Lehmann M. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol Infect. 2007; 135(2): 274-80[DOI][PubMed]
  • 11. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. Journal of Hepatology.; 28(1): 27-33[DOI]
  • 12. Stroffolini T, D'Egidio PF, Aceti A, Filippini P, Puoti M, Leonardi C, et al. Hepatitis C virus infection among drug addicts in Italy. J Med Virol. 2012; 84(10): 1608-12[DOI][PubMed]
  • 13. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000; 3(2): 121-6[PubMed]
  • 14. Skipper C, Guy JM, Parkes J, Roderick P, Rosenberg WM. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy. Gut. 2003; 52(10): 1500-4[PubMed]
  • 15. Kassaian N, Adibi P. Hepatitis C virus and associated risk factors among prison inmates with history of drug injection in Isfahan, Iran. Int J Prev Med. 2012; 3: 165-1
  • 16. Vallabhaneni S, Macalino GE, Reinert SE, Schwartzapfel B, Wolf FA, Rich JD. Prisoners favour hepatitis C testing and treatment. Epidemiol Infect. 2006; 134(2): 243-8[DOI][PubMed]
  • 17. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ. 2000; 321(7253): 78-82[PubMed]
  • 18. Murcia J, Portilla J, Bedia M, Palazon JM, Sanchez-Paya J, Saiz de la Hoya P, et al. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison]. Enferm Infecc Microbiol Clin. 2009; 27(4): 206-12[DOI][PubMed]
  • 19. Farley JD, Wong VK, Chung HV, Lim E, Walters G, Farley TA, et al. Treatment of chronic hepatitis C in Canadian prison inmates. Can J Gastroenterol. 2005; 19(3): 153-6[PubMed]
  • 20. Santos BF, de Santana NO, Franca AV. Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil. World J Gastroenterol. 2011; 17(25): 3027-34[DOI][PubMed]
  • 21. Tyczyno M. HCV genotypes among patients diagnosed in Bydgoszcz. MSR Hepatol. 2007; 7: 77-9
  • 22. Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, et al. Changing HCV genotypes distribution in Poland--relation to source and time of infection. J Clin Virol. 2008; 42(2): 156-9[DOI][PubMed]
  • 23. Januszkiewicz-Lewandowska D, Wysocki J, Rembowska J, Pernak M, Lewandowski K, Nowak T, et al. Transmission of HCV infection among long-term hospitalized onco-haematological patients. J Hosp Infect. 2003; 53(2): 120-3[PubMed]
  • 24. Touceda S, Pereira M, Agulla A. Prevalence of hepatitis C virus genotype in the areao of El Ferrol (La Coruna, Spain). . Enferm Infecc Microbiol Clin. 2002; 20(5): 200-4
  • 25. Grabczewska E, Pawlowska M, Halota W. Epidemiological aspects of HCV-HIV co-infections. HIV AIDS Rev. 2003; 2: 123-6
  • 26. Babik JM, Holodniy M. Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients. J Virol. 2003; 77(3): 1940-50[PubMed]
  • 27. Krekulova L, Rehak V, Madrigal N. Genotypic and epidemiologic characteristics of hepatitis C virus infection among recent injection drug users and nonusers populations. Clin Infect Dis. 2001; 15(8): 1435-8
  • 28. Poveda E, Vispo E, Barreiro P, de Mendoza C, Labarga P, Fernandez-Montero JV, et al. Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain. Antivir Ther. 2012; 17(3): 571-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments